A. Younes Et Al. , "Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma," HAEMATOLOGICA , vol.102, no.12, pp.2104-2112, 2017
Younes, A. Et Al. 2017. Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma. HAEMATOLOGICA , vol.102, no.12 , 2104-2112.
Younes, A., Salles, G., Martinelli, G., Bociek, R. G., Barrigon, D. C., Barca, E. G., ... Turgut, M.(2017). Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma. HAEMATOLOGICA , vol.102, no.12, 2104-2112.
Younes, Anas Et Al. "Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma," HAEMATOLOGICA , vol.102, no.12, 2104-2112, 2017
Younes, Anas Et Al. "Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma." HAEMATOLOGICA , vol.102, no.12, pp.2104-2112, 2017
Younes, A. Et Al. (2017) . "Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma." HAEMATOLOGICA , vol.102, no.12, pp.2104-2112.
@article{article, author={Anas Younes Et Al. }, title={Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma}, journal={HAEMATOLOGICA}, year=2017, pages={2104-2112} }